Biologics Market Industry Insights, Outlook, Analysis, and Forecast 2018-2026
Most recent approval by Pfizer is DAURISMO (glasdegib) in U.S. for adult patients with newly-diagnosed acute myeloid leukemia for whom intensive chemotherapy is not an option.
